PubMed Health⌕ Search

Biomedical subjects

B Adam

Publications and source records attributed to B Adam.

58 records · Page 4Linked to original sources

Formation of nitrite in gastric juice of patients with various gastric disorders after ingestion of a standard dose of nitrate--a possible risk factor in gastric carcinogenesis.

Samples of fasting gastric juice (12-h fasting period) from patients with various upper gastrointestinal complaints and from healthy controls were collected by aspiration immediately before and 30, 90, and 240 min after ingestion of 200 mg nitrate in water. Nitrite concentration in the gastric juice of healthy controls remained essentially in a low concentration range throughout the whole sampling period (median values at various time points, 0.1-1.7 mg/L). Patients with gastric and duodenal ulcers and patients who had undergone proximal-gastral vagotomy did not show significant increases in gastric nitrite at any time when compared with healthy controls, using the Wilcoxon rank sum test. Patients with chronic atrophic gastritis and those who had undergone Billroth I or Billroth II gastric resection, however, showed significant increases in gastric nitrite, sometimes with high individual peaks: 80 mg/L in one patient with chronic atrophic gastritis, 50 mg/L in a Billroth I patient and 200 mg/L in a Billroth II patient. The results show that patients with chronic atrophic gastritis and patients who have undergone Billroth I and Billroth II gastrotomy not only have higher basal nitrite values in their gastric juice (12-h fasting) but also react with significantly higher increases in gastric nitrite to an oral dose of 200 mg nitrate, compared with healthy controls, ulcer patients and patients who have undergone proximal-gastral vagotomy. Higher nitrite levels might lead to an enhanced intragastric formation of N-nitroso compounds, and this might be relevant to the increased gastric cancer risk of these groups of patients.

Duodenal Ulcer↗

Levels of stable metabolites of prostacyclin and thromboxane A2 and their ratio in normotensive and preeclamptic pregnant women during the antepartum and postpartum periods.

OBJECTIVE: To measure the levels of the circulating metabolites of prostacyclin and thromboxane A2 during the antepartum and postpartum periods in severe preeclamptic and eclamptic patients as well as in normotensive pregnant women. METHODS: 6-Keto-prostaglandin F1alpha (6-keto-PGF1alpha) and thromboxane B2 (TxB2) were measured in the plasma of 15 severe preeclamptic, 15 eclamptic, and 15 normotensive pregnant women during the antepartum and postpartum (5th day) periods. At the same time blood pressure measurements were obtained. Kruskal-Wallis, Wilcoxon rank-sum, and Wilcoxon's signed-rank tests were used for statistical analysis. RESULTS: 1) There was no significant difference in the levels of 6-keto-PGF1alpha and TxB2 of the normotensive pregnant women between the antepartum and the postpartum (5th day) periods. 2) In the severe preeclamptic and eclamptic groups, 6-keto-PGF1alpha levels showed significant increase after the delivery (P < 0.01, and P < 0.001, respectively). 3) In the severe preeclamptic and eclamptic groups TxB2 levels showed significant decrease after delivery (P < 0.01, and P < 0.001, respectively). 4) The 6-keto-PGF1alpha/TxB2 ratio both during the antepartum and the postpartum (5th day) periods showed significant differences between the severe preeclamptic and normotensive, and between the eclamptic and normotensive groups (P < 0.001, and P < 0.001 respectively). 5) No correlation was observed between the mean arterial pressure and the antepartum levels of 6-keto-PGF1alpha TxB2 or their ratios. CONCLUSIONS: Our study was able to demonstrate a significant difference in circulating metabolites of prostacyclin and TxA2 between normotensive pregnant women and those with severe preeclampsia and eclampsia. But no correlation was observed between the blood pressure and the antepartum 6-keto-PGF1alpha, TxB2 levels or their ratios. 6-keto-PGF1alpha levels increased and TxB2 levels decreased in the postpartum period (5th day). However, the 6-keto-PGF1alpha/TxB2 ratio was still low in the severe preeclamptic and eclamptic patients when compared with the control group. This situation shows that the pathophysiologic mechanism does not improve completely within a few days after delivery.

6-Ketoprostaglandin F1 alpha↗

Atrial natriuretic peptide and aldosterone in sick premature neonates.

Plasma atrial natriuretic peptide (ANP) and aldosterone concentrations were investigated in 25 sick premature neonates. Group A consisted of 11 premature neonates with sepsis and group B of 14 neonates with hyperbilirubinemia. In both groups, ANP and aldosterone levels were found to be higher than in the controls. Group A concentrations of ANP and aldosterone were also higher than in group B.

Aldosterone↗

Acute effect of trandolapril on serum erythropoietin in uremic and hypertensive patients.

Anemia associated with ACE inhibitors is rare but it may cause problems especially in patients with renal disease. This study assessed the acute effect of trandolapril, an ACE inhibitor, on serum erythropoietin (EPO) levels in uremic and hypertensive patients. Trandolapril 2 mg/day was given orally for three days and blood samples were collected on the first and third day. Trandolapril led to a significant decrease in serum EPO in patients with chronic renal failure. Although the drug lowered serum EPO in hypertensive patients, this effect was not statistically significant. This drop in serum EPO levels may be one of the mechanisms by which ACE inhibitors cause anemia, or worsen anemia, in uremic patients and further studies are needed to clarify this point.

Adult↗